Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Receives $7.4m R&D Tax Incentive Refund

Nov 18, 2022 at 8:27 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment